AgomelatineisamelatoninMT1/2receptoractivatorthatalsoinhibits5-HT2Creceptors.Agomelatinedisplaysantidepressant,anxiolytic,andhypnoticcharacteristicsandiscurrentlybeingexaminedasamarketableantidepressant.Agomelatineimprovessleepqualityandefficacyandtreatsinsomnia.Thiscompoundalsoenhancesneuroplasticityandneurogenesisinthehippocampusandprefrontalcortex.
| CasNo. | 138112-76-2 |
|---|---|
| Purity | ≥98% |
| Formula | C15H17NO2 |
| FormulaWt. | 243.30 |
| IUPACName | N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | A2658MSDSPDF |
|---|---|
| InfoSheet | A2658InfoSheetPDF |
SmeraldiE,DelmonteD.Agomelatineindepression.ExpertOpinDrugSaf.2013Nov;12(6):873-80.PMID:24033095.
PompiliM,SerafiniG,InnamoratiM,etal.Agomelatine,anovelintriguingantidepressantoptionenhancingneuroplasticity:acriticalreview.WorldJBiolPsychiatry.2013Aug;14(6):412-31.PMID:23530731.
SrinivasanV,ZakariaR,OthamanZ,etal.Melatonergicdrugsfortherapeuticuseininsomniaandsleepdisturbancesofmooddisorders.CNSNeurolDisordDrugTargets.2012Mar;11(2):180-9.PMID:22483286.
Bertaina-AngladeV,laRochelleCD,BoyerPA,etal.Antidepressant-likeeffectsofagomelatine(S20098)inthelearnedhelplessnessmodel.BehavPharmacol.2006Dec;17(8):703-13.PMID:17110796.
PappM,LitwaE,GrucaP,etal.Anxiolytic-likeactivityofagomelatineandmelatonininthreeanimalmodelsofanxiety.BehavPharmacol.2006Feb;17(1):9-18.PMID:16377959.
